CLINICAL_TRIALS
research
· 2026-04-20
Clinical Trial Update: Genetic Analysis of Immune Disorders
Summary
This Clinical Trial Update notes that an NIAID study is recruiting to analyze genetic immune disorders linked to STAT1, GATA2, and STAT3 pathways.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: DOK 8, STAT1 | Status: RECRUITING